» Authors » Lawrence A Silverman

Lawrence A Silverman

Explore the profile of Lawrence A Silverman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 98
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Deal C, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman L, Phillip M, et al.
Ther Adv Endocrinol Metab . 2024 Nov; 15:20420188241277404. PMID: 39526285
• The efficacy of weekly injections was no different from that of daily injections to treat children who don't make enough growth to grow adequately. ○ Efficacy refers to how...
2.
Bangalore Krishna K, Silverman L
Endocrinol Metab Clin North Am . 2024 Apr; 53(2):217-227. PMID: 38677865
A thorough history and physical examination including Tanner staging and growth assessments can guide differential diagnosis and aid in the evaluation of precocious puberty. Basal luteinizing hormone levels measured using...
3.
Silverman L, Geffner M, Benson M
Horm Res Paediatr . 2024 Apr; :1-8. PMID: 38653206
Introduction: Studies of gonadotropin-releasing hormone analogues (intramuscular [IM] leuprolide acetate [LA] and triptorelin) for treatment monitoring of central precocious puberty (CPP) demonstrate this approach is effective for confirming pubertal hormone...
4.
Moise-Silverman J, Silverman L
Front Endocrinol (Lausanne) . 2022 Dec; 13:1029137. PMID: 36531492
Gonadotrophin dependent sexual precocity, commonly referred to as central precocious puberty (CPP), results from a premature reactivation of the hypothalamic-pituitary-gonadal (HPG) axis before the normal age of pubertal onset. CPP...
5.
Popovic J, Geffner M, Rogol A, Silverman L, Kaplowitz P, Mauras N, et al.
Front Pediatr . 2022 Oct; 10:968485. PMID: 36268040
Gonadotropin-releasing hormone agonists (GnRHa's) are the standard treatment for children with central precocious puberty (CPP). We aim to present data on available GnRHa options with an easy-to-review table and discuss...
6.
Loftus J, Chen Y, Gupta A, Wajnrajch M, Alvir J, Silverman L, et al.
Curr Med Res Opin . 2022 Apr; 38(6):917-925. PMID: 35477409
Objective: The objective of this retrospective cohort study was to describe the adherence and discontinuation patterns of somatropin over 3 years among children with pGHD insured by Medicaid across the...
7.
Deal C, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman L, Phillip M, et al.
J Clin Endocrinol Metab . 2022 Apr; 107(7):e2717-e2728. PMID: 35405011
Context: Somatrogon is a long-acting recombinant human growth hormone (rhGH) in development for once-weekly treatment of children with growth hormone deficiency (GHD). Objective: We aimed to compare the efficacy and...
8.
Silverman L, Han X, Huang H, Near A, Hu Y
J Pediatr Endocrinol Metab . 2021 Jun; 34(8):961-969. PMID: 34147047
Objectives: Gonadotropin-releasing hormone analogs are the treatment of choice for central precocious puberty (CPP). This study characterizes patients treated with histrelin implant or leuprolide injection. Methods: A US claims database...
9.
Ross J, Bloy L, Roberts T, Miller J, Xing C, Silverman L, et al.
Am J Med Genet B Neuropsychiatr Genet . 2019 Jun; 180(7):471-482. PMID: 31161682
We describe a unique male with a dicentric Y chromosome whose phenotype was compared to that of males with 47,XYY (XYY). The male Y-chromosome aneuploidy XYY is associated with physical,...
10.
Yeliosof O, Silverman L
J Pediatr Endocrinol Metab . 2018 Jan; 31(1):91-94. PMID: 29303778
Background: Iodine deficiency is the most common cause of acquired hypothyroidism worldwide. Although uncommon in the Western world, the incidence of iodine deficiency may be rising due to the increased...